Skip to main content



D2B3 - Drug Delivery across the Blood Brain Barrier

Development of a New Class of Therapeutics to Treat Poisoning Diseases

Biotherapeutic for Systemic Sclerosis

Dual MIF - D-DT Targeting to Enhance Immunotherapy Responses

Rosevix (Rosziqumab) A ROS1 Biologic for Invasive Cancers

Epiregulin Inhibition to Treat Scleroderma Skin and Lung Fibrosis

Subscribe to Antibody